Lactation Suppressants Market
Number of pages: 100 | Report Format: PDF | Published date: May 11, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
CAGR |
6.8% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Drug Class, Distribution Channel, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global lactation suppressants market is expected to grow at a revenue CAGR of 6.8% from 2023 to 2031.
Lactation Suppressants Market Fundamentals
Lactation suppressants, also known as lactation inhibitors or lactation suppressor medications, are medications used to reduce or suppress milk production in breastfeeding individuals. They are typically used in situations where breastfeeding is not possible or desired, such as when a person has decided not to breastfeed, experiences medical complications, or is taking medications that are contraindicated during breastfeeding.
The global lactation suppressants industry analysis report comprehensively analyzes the market, with the factors that either aid or impede the market growth, such as its drivers, restraints, and opportunities. The research provides insight into the companies that operate in the lactation suppressants market and their efforts to position themselves as key players through expansion strategies and innovations. It also highlights recent developments that contribute to the lactation suppressants market growth. The research also analyzes the impact of the COVID-19 pandemic.
This research is valuable for businesses seeking insights into the market, customers, and competition. The research provides special insights into the segmentation, regions, market size & projection, revenue CAGRs, and other important information that may help clients make the right decisions. The report assembles data from market players and professionals across the industrial value chain. The study also incorporates qualitative and quantitative assessments from industry professionals. Secondary research, surveys and interviews, and statistical modeling are all used in our research to estimate market size and projection. Our reports deliver the most reliable market data because of our specialized research methods.
Lactation Suppressants Market Dynamics
There is a rise in medical conditions, such as hyperprolactinemia, hormonal imbalances, or specific types of tumors, which can lead to the need to suppress lactation. Lactation suppressants provide a therapeutic solution in such cases, driving the demand for these medications. The upward trend in birth rates is influencing individual decisions related to breastfeeding. Some individuals may choose not to breastfeed or prefer to wean earlier due to personal preferences, lifestyle factors, or various considerations. As a result, there is an increased demand for lactation suppressants to facilitate the reduction or inhibition of milk production. According to the Centers for Disease Control and Prevention (CDC), a total of 3,664,292 births were registered in the U.S. in 2021, up by 1% from 2020. The general fertility rate rose 1% from 2020 to 56.3 births per 1,000 women in 2020 to 1,664.0 births per 1,000 women in 2021. The market for lactation suppressants can be influenced by the increasing adoption of alternative feeding methods, such as infant formula or donor milk. Individuals who opt for these feeding methods may seek lactation suppressants to stop or reduce milk production. Certain medications or medical conditions may be contraindicated during breastfeeding. In such situations, lactation suppressants can be prescribed to temporarily inhibit milk production, ensuring the safety of both the breastfeeding individual and the baby.
However, lactation suppressants have potential side effects, varying depending on the specific suppressant used. Concerns regarding side effects, especially in relation to the potential impact on the health and well-being of the breastfeeding individual, are restricting the growth of the lactation suppressants market. There is a strong emphasis on promoting and supporting breastfeeding due to its numerous health benefits for both the baby and the breastfeeding individual. This emphasis can act as a restraint on the uptake of lactation suppressants.
Lactation Suppressants Market Ecosystem
Lactation Suppressants Market, by Drug Class
Lactation Suppressants Market, by Distribution Channel
Lactation Suppressants Market by Drug Class
[45674]
The estrogens segment accounted for the largest revenue share of the lactation suppressants market in 2022. Estrogen-containing lactation suppressants work by inhibiting the release of prolactin, a hormone responsible for milk production. Estrogen suppresses the production and secretion of prolactin, thereby reducing milk supply. This mechanism of action is well-established and has been widely studied, contributing to the dominance of estrogen-based lactation suppressants. Healthcare providers, including obstetricians and gynecologists, often prescribe estrogen-based lactation suppressants due to their established efficacy and safety profile. Physician prescribing practices play a significant role in shaping the dominant segment of the lactation suppressants market, as they tend to rely on medications, they are familiar with and have experience using. Estrogen-based lactation suppressants have gained significant consumer awareness and acceptance. Many individuals are familiar with the use of hormonal contraceptives and may be more inclined to consider them as lactation suppressants. This awareness and acceptance contribute to the dominance of the estrogen segment in the lactation suppressants market.
The market segmentation sections provide the lactation suppressants market outlook in terms of the demarcation of different consumer groups. Market segmentation is the split of an industry into subgroups depending on characteristics such as drug class, distribution channel and other factors. Market segmentation data helps organizations understand the preferences and distinctive demands of different customer groups and implement targeted marketing strategies. This data additionally helps in identifying potential lactation suppressants market demand opportunities.
Lactation Suppressants Market by Region
North America places significant emphasis on women's health, including reproductive health and maternal care. There is a strong awareness of the benefits of breastfeeding, but also an understanding that some individuals may require lactation suppressants due to medical conditions or personal circumstances. This awareness drives the demand for lactation suppressants as a therapeutic option. North America benefits from advanced healthcare infrastructure and technological advancements, including well-established pharmaceutical companies and research institutions. These advancements facilitate the development, availability, and accessibility of lactation suppressants in the market. Factors such as delayed childbearing, career-oriented lifestyles, and cultural shifts influence breastfeeding patterns in North America. These factors can contribute to a greater demand for lactation suppressants as individuals make choices that align with their lifestyle and personal circumstances. According to the U.S. Bureau of Labor Statistics in 2022, the unemployment rate for mothers decreased by 1.6 percentage points from the prior year to 3.4 percent. North America accounts for approximately 40% of the global lactation suppressants market in 2022.
Based on the regions, the global lactation suppressants market is segmented into:
The industry's regional segmentation provides insights into geographic pockets in terms of lactation suppressants industry trends, market size, share, and growth rate. This information helps organizations assess potential growth opportunities in new regional markets, understand competitive threats, and develop localized sales and expansion strategies. This section also offers deeper insights into the regional and country-level lactation suppressants market overview.
Key Components of the Report
Lactation Suppressants Market Competitive Landscape
The market competitive landscape analysis is performed by gathering and evaluating data about the key competitors, industry trends, and market dynamics. It involves collecting and analyzing data on factors such as products, pricing, geographic reach, customer demographics, marketing tactics, and recent developments. Competitive landscape analysis can help organizations identify present or prospective opportunities and risks in the market.
Lactation Suppressants Market Recent Developments
Reasons To Buy This Report
Key Strengths of Our Report
Target Audience to Benefit from this Report.
Lactation suppressants, also known as lactation inhibitors or lactation suppressor medications, are substances or medications used to reduce or suppress milk production in breastfeeding individuals.
The North America region is expected to have the largest lactation suppressants market size during the forecast period from 2023 to 2031.
The lactation suppressants market is expected to register a revenue CAGR of 6.8% during the forecast period from 2023 to 2031.
There is an opportunity for the development of more targeted and specific lactation suppressant therapies.
Market players are forming collaborations and partnerships with groups and healthcare institutions to develop awareness about the available therapies.
The prominent players operating in the global lactation suppressants market are AA Pharma Inc., Pharmel Inc., Viatris Inc., Novartis AG, and Teva Pharmaceutical Industries Ltd.
The estrogen segment dominated the lactation suppressants market.
Emphasis on breastfeeding promotion and the side effects of the medication are some of the restricting factors of the lactation suppressants market.
Adoption of alternative feeding methods and growing R&D related to lactation suppressants are some of the major driving factors of the market.
*Insights on financial performance are subject to the availability of information in the public domain
Recommended Reports